Multipotent mesenchymal stromal cells and immune tolerance

被引:110
|
作者
Noel, Daniele
Djouad, Farida
Bouffi, Carine
Mrugala, Dominique
Jorgensen, Christian
机构
[1] INSERM, U844, Montpellier, France
[2] Univ Montpellier I, UFR Med, Montpellier, France
[3] Hop St Eloi, Unite Therapie Cellulaire & Genique, Montpellier, France
[4] NIH, Cartilage Biol & Orthopaed Branch, Bethesda, MD USA
[5] Hop Lapeyronie, Serv Immunol Rhumatol, Montpellier, France
关键词
mesenchymal stem cell; immunosuppression; characterization;
D O I
10.1080/10428190701361869
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Multipotent mesenchymal stromal cells or mesenchymal stem cells ( MSC) are isolated mainly from bone marrow and adipose tissue but are identified in other tissues such as synovium, periosteum or placenta. They are characterised by their property to adhere to plastic, their phenotype and their ability to differentiate into three lineages ( chondrocytes, osteoblasts and adipocytes). More recently, these cells were shown to escape immune recognition and inhibit immune responses. MSC may modulate the function of the major immune cell populations, including antigen-presenting cells, T cells, B cells and natural killer cells. The aim of this review is to focus on the molecular mechanisms, still poorly understood, which are responsible of the immunosuppressive effects mediated by the MSC. Finally, the data obtained from in vivo experimentation in various animal models as well as potential therapeutic applications will be presented.
引用
收藏
页码:1283 / 1289
页数:7
相关论文
共 50 条
  • [41] Risk of genetic transformation of multipotent mesenchymal stromal cells in vitro
    V. A. Nikitina
    A. I. Chausheva
    Russian Journal of Genetics, 2014, 50 : 91 - 95
  • [42] Multipotent Mesenchymal Stromal Cells: Possible Culprits in Solid Tumors?
    Johann, Pascal David
    Mueller, Ingo
    STEM CELLS INTERNATIONAL, 2015, 2015
  • [43] Expanding autologous multipotent mesenchymal bone marrow stromal cells
    Brinchmann, Jan E.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2008, 265 (1-2) : 127 - 130
  • [44] Changing the Properties of Multipotent Mesenchymal Stromal Cells by IFNγ Administration
    Petinati, N. A.
    Kapranov, N. M.
    Bigil'deev, A. E.
    Popova, M. D.
    Davydova, Yu. O.
    Gal'tseva, I. V.
    Drize, N. I.
    Kuz'mina, L. A.
    Parovichnikova, E. N.
    Savchenko, V. G.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2017, 163 (02) : 230 - 234
  • [45] Risk of genetic transformation of multipotent mesenchymal stromal cells in vitro
    Nikitina, V. A.
    Chausheva, A. I.
    RUSSIAN JOURNAL OF GENETICS, 2014, 50 (01) : 91 - 95
  • [46] Concise Review: MicroRNA Function in Multipotent Mesenchymal Stromal Cells
    Clark, Elizabeth A.
    Kalomoiris, Stefanos
    Nolta, Jan A.
    Fierro, Fernando A.
    STEM CELLS, 2014, 32 (05) : 1074 - 1082
  • [47] Xenogeneic Protein Free Cultivation of Mesenchymal Multipotent Stromal Cells
    Stehlik, D.
    Pytlik, R.
    Rychtrmocova, H.
    Vesela, R.
    Kopecny, Z.
    Trc, T.
    ACTA CHIRURGIAE ORTHOPAEDICAE ET TRAUMATOLOGIAE CECHOSLOVACA, 2011, 78 (06) : 537 - 543
  • [48] Changing the Properties of Multipotent Mesenchymal Stromal Cells by IFNγ Administration
    N. A. Petinati
    N. M. Kapranov
    A. E. Bigil’deev
    M. D. Popova
    Yu. O. Davydova
    I. V. Gal’tseva
    N. I. Drize
    L. A. Kuz’mina
    E. N. Parovichnikova
    V. G. Savchenko
    Bulletin of Experimental Biology and Medicine, 2017, 163 : 230 - 234
  • [49] Rationale for the use of multipotent mesenchymal stromal cells in multiple sclerosis
    Connick, Peter V.
    Kolappan, Madhan
    Miller, David H.
    Compston, Alastair
    Chandran, Siddharthan
    MULTIPLE SCLEROSIS, 2008, 14 : S38 - S38
  • [50] MULTIPOTENT MESENCHYMAL STROMAL CELLS: Clinical Applications and Cancer Modeling
    Rodriguez, Rene
    Garcia-Castro, Javier
    Trigueros, Cesar
    Garcia Arranz, Mariano
    Menendez, Pablo
    STEM CELL TRANSPLANTATION, 2012, 741 : 187 - 205